Variables* | At the start | 6 weeks | 12 weeks | P value†
|
---|
TALP (IU/l) | 237.5 ± 85.4** | 300.4 ± 294.1 | 281.3 ± 80.5 |
<0.05
|
OC (ng/ml) | 11.4 ± 4.8 | 12.7 ± 5.7 | 11.5 ± 4.8 |
NS
††
|
IGFBP3 (ng/ml) | 3304.6 ± 728.6 | 3221.6 ± 534.4 | 3103.9 ± 639.8 |
NS
|
DPD (nmol/mmol) | 7 ± 1.2 | 5.9 ± 1.1 | 5.1 ± 2.1 |
<0.05
|
C-TX (ng/ml) | 0.79 ± 0.49 | 0.8 ± 0.4 | 0.8 ± 0.3 |
NS
|
ITCP (μg/l) | 4.6 ± 0.9 | 4.3 ± 0.9 | 5.9 ± 1.1 |
NS
|
- * TALP: Total alkaline phosphatase (IU/l); OC: Osteocalcin (ng/ml); IGFBP3: Insulin like growth factor binding protein 3 (ng/ml); DPD: Deoxypyridinoline (nmol/mmol); C-TX: C-Telopeptides (ng/ml); ITCP: Carboxy terminal telopeptides of type I collagen (μg/l)
- ** Mean ± SD
- † To analyze changes in 3 stages, repeated measurement analysis was utilized.
- †† significant level was set at below 5 percent (P < 0.05).